PUNE, India, June 23, 2016 /PRNewswire-iReach/ -- Objective of Study
Photo - http://photos.prnewswire.com/prnh/20160623/382733
Access a report copy of 110 pages at http://www.marketresearchfuture.com/reports/global-human-insulin-market-forecast-to-2027 .
Human insulin refers to synthetic insulin manufactured in laboratories by growing insulin protein with the help of E. coli bacteria. Previously, before human insulin was established as animal insulin, usually a purified form of porcine (pork) insulin was used. It is expected that the market for global human insulin market is expected to grow at a CAGR of 12.1% from 2016 – 2027.
Key findings of this report
- Increasing prevalence of diabetic population, rising prevalence of obesity, and rise in geriatric population are major factors driving the growth of the human insulin market
- Strict regulatory requirements for approval of insulin and high cost of insulin analog inhibits the growth of the human insulin market
Request a Sample Copy @ http://www.marketresearchfuture.com/sample-request/global-human-insulin-market-forecast-to-2027 .
Segmentation for the global human insulin market comprises of the following types such as
- Traditional Human Insulin which comprises of Short Acting Human Insulin, Intermediate Acting Human Insulin, and Premixed Human Insulin.
- Modern Human Insulin which consists of Long Acting Human Insulin, Rapid Acting Human Insulin and Premixed Human Insulin
Regional Analysis of Human Insulin Market:
North America is a prominent market for human insulin market and dominated the Global market share. It has been valued at $11,127.9 in 2015 million and is expected to grow over $XX million by 2027. The European human insulin market stands as second largest market which is expected to grow with a CAGR of 12.2% during the forecasted period. Asia Pacific has emerged as the fastest growing market which has been valued at US $6,298 million in 2015 and expected to reach US $XX million by the end of forecasted period with the CAGR of more than 13.2%.
Key Players for Human Insulin Market:
Some of the key players for this market are: Biocon Ltd, Tonghua Dongbao Pharmaceuticals Co., Ltd., ADOCIA, Merck & Co, Julphar, Pfizer, Inc, Bristol-Myers Squibb Company, GlaxoSmithKline, Oramed Pharmaceuticals, Inc, Novo Nordisk A/S and Sanofi.
Purchase a 1-User License Copy at http://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=849 .
firstname.lastname@example.org+1 (646) 845 9349 (US)+44 208 133 9349 (UK)
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Media Contact: Norah Trent, Market Research Future, +1 646 845 9349, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Market Research Future
Subscribe to our Free Newsletters!